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Summary  Laryngomalacia  is  the  most  common  laryngeal  disease  of  infancy.  It  is  poorly  tol-
erated in  10%  of  cases,  requiring  assessment  and  management,  generally  surgical.  Surgery
often consists  of  supraglottoplasty,  for  which  a  large  number  of  technical  variants  have  been
described. This  surgery,  performed  in  an  appropriate  setting,  relieves  the  symptoms  in  the  greatLaser;
Supraglottoplasty
majority of  cases  with  low  morbidity.  However,  few  data  are  available  concerning  the  objec-
tive results:  preoperative  and  postoperative  objective  assessment  of  these  infants  is  therefore
necessary  whenever  possible.  Noninvasive  ventilation  (NIV)  may  be  indicated  in  some  infants
with comorbid  conditions  or  failing  to  respond  to  surgical  management.
© 2012  Elsevier  Masson  SAS.  All  rights  reserved.
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•Laryngomalacia  is  deﬁned  as  collapse  of  supraglottic
structures  during  inspiration.  Most  forms  of  laryngomalacia
are  minor  (70—90%),  presenting  in  the  form  of  isolated
and  intermittent  stridor  with  no  alteration  of  crying  or
coughing,  no  dyspnoea,  and  no  swallowing  disorders.  These
minor  forms  do  not  have  any  consequences  on  the  infant’s
growth  and  simply  require  surveillance  by  the  paediatrician
or  general  practitioner  to  detect  any  signs  of  severity.
Only  severe  forms  of  laryngomalacia  require  therapeutic
intervention.
Signs  of  severity  are:
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1879-7296/$ – see front matter © 2012 Elsevier Masson SAS. All rights re
doi:10.1016/j.anorl.2012.04.003 poor  weight  gain  (probably  the  most  contributive  ele-
ment);
dyspnoea  with  permanent  and  severe  intercostal  or
xyphoid  retraction;
 episodes  of  respiratory  distress;
 obstructive  sleep  apnoea;
 episodes  of  suffocation  while  feeding  or  feeding  difﬁcul-
ties.
Endoscopy  under  general  anaesthesia  must  be
ystematically  performed  in  these  severe  forms  to  conﬁrm
he  diagnosis  and  exclude  an  associated  respiratory  tract
esion,  present  in  18.9%  of  cases  in  the  series  published
y  Mancuso  et  al.  [1].  Associated  laryngotracheal  lesions
laryngeal  dyskinesia,  vocal  cord  paralysis,  subglottic
tenosis,  tracheomalacia)  are  more  frequent  in  the  pres-
served.
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nce  of  severe  laryngomalacia:  Dickson  et  al.  [2]  reported
ssociated  lesions  in  79%  of  cases  (with  subglottic  stenosis
n  73.3%  of  cases  and  tracheomalacia  in  55.3%  of  cases)  in
nfants  with  severe  laryngomalacia  versus  28.8%  of  infants
ith  laryngomalacia  associated  with  few  signs  of  severity.
edical treatment and laryngomalacia
ue  to  the  frequency  and  exacerbating  role  of  pharyn-
olaryngeal  reﬂux  (PLR)  in  infants  with  laryngomalacia,
nti-reﬂux  treatment  should  be  prescribed,  despite  the
bsence  of  evidence  in  favour  of  this  approach  in  the
iterature  (expert  opinion).
Lifestyle  and  dietary  measures  must  always  be  instituted
thickened  milk,  maintenance  of  posture  after  feeds,  no  bot-
le  of  water  before  lying  down,  raising  of  the  head  of  the  bed
r  mattress),  and  antacids  in  infants  with  regurgitation.
No  studies  have  determined  the  optimal  dose  and  dura-
ion  of  H2  histamine  antagonist  or  proton  pump  inhibitor
PPI)  therapy  or  the  preferred  molecule.  Ranitidine  can  be
sed  at  the  dose  of  3  mg/kg/day  and  PPIs  can  be  used  at  the
ose  of  1  to  2  mg/kg/day.  The  efﬁcacy  of  this  treatment  has
een  reported  in  several  studies,  but  no  double-blind  trials
ave  been  conducted  [3].
In  2011,  the  SFORL  expert  group  recommended  medical
reatment  for  laryngomalacia  with  signs  of  severity,  or  in  the
resence  of  characteristic  signs  of  pharyngolaryngeal  reﬂux
n  pharyngolaryngeal  endoscopy.
PPI  therapy  is  also  recommended  postoperatively  in
nfants  treated  by  supraglottoplasty  procedures:  cases  of
ostoperative  stenosis  have  been  reported  in  infants  with
astro-oesophageal  reﬂux,  but  the  pathogenic  role  of  gastro-
esophageal  reﬂux  simply  remains  suspected  [4].
No  study  has  conﬁrmed  the  efﬁcacy  of  local  or  systemic
orticosteroid  therapy  in  laryngomalacia.
urgical treatment of laryngomalacia
ethods
part  from  tracheotomy,  which  remained  the  reference
urgical  treatment  for  severe  forms  of  laryngomalacia
or  many  years,  several  other  surgical  techniques  have
een  proposed  and  have  been  gradually  transformed  into
inimally  invasive  endoscopic  approaches.
Variot  [5],  in  1898,  was  the  ﬁrst  to  propose  resection
f  the  excess  mucosal  tissue  on  the  aryepiglottic  folds,
ased  on  the  post-mortem  ﬁndings  in  a  neonate  with
tridor.  In  1922,  Iglauer  [5]  was  the  ﬁrst  to  perform  partial
piglottectomy  in  a  patient  with  laryngomalacia  with  a
avourable  outcome.  In  1928,  Hasslinger  [5]  performed
ndoscopic  forceps  division  of  the  aryepiglottic  folds  in
hree  patients  with  good  results.  In  1971,  Fearon  et  al.
6]  reported  cases  of  suture  of  the  epiglottis  to  the  base
f  the  tongue,  allowing  extubation  of  their  patients.
uring  the  same  period,  cases  of  hyomandibulopexy  were
eported  in  France  with  satisfactory  initial  results  [7],
ut  this  technique  was  subsequently  abandoned.  In  1981,
empler  et  al.  [8]  performed  resection  of  the  epiglottis,
entricular  folds  and  aryepiglottic  folds  via  lateral  pharyn-
otomy  in  an  18-year-old  patient  with  a  satisfactory  result.
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he  publication  by  Lane  et  al.  [9]  reporting  endoscopic
reatment  of  laryngomalacia  with  resection  of  excess  supra-
rytenoid  mucosal  tissue  and  the  epiglottic  mucosa  using
icroinstruments  (microforceps  and  microscissors)  led  to
 renewed  interest  in  these  endoscopic  treatments.  One
ear  later,  Seid  et  al.  [10]  used  the  CO2 laser  to  divide  short
ryepiglottic  folds  in  three  patients.  Following  numerous
ubsequent  publications  [11—13]  endoscopic  treatment  of
aryngomalacia  has  become  the  standard  treatment.
naesthesia
he  main  methods  of  ventilation  are:
 mechanically  controlled  ventilation  via  a  small  calibre
endotracheal  tube  is  rarely  used,  as  it  interferes  with  the
surgical  procedure;
spontaneous  breathing  anaesthesia,  which  constitutes  the
technique  of  choice  of  experienced  anaesthetist-surgeon
teams;
intermittent  apnoea  technique  that  provides  the  sur-
geon  with  only  a  limited  time  to  perform  the  procedure
between  two  reintubations.
Jet  ventilation,  sometimes  described  for  this  surgery,  has
ot  been  validated  for  laryngeal  obstructive  diseases  such  as
evere  laryngomalacia.
urgical  technique
ost  of  the  new  surgical  techniques  used  in  this  disease,
alled  supraglottoplasties,  are  designed  to  reduce  the
xcess  tissues  on  supraglottic  structures  responsible  for  col-
apse.  Several  improvements  have  been  proposed  over  time,
ot  only  concerning  the  endoscopic  surgical  technique,
ut  also  concerning  the  methods  used  to  resect  excess
issues.  Since  the  ﬁrst  descriptions  of  supraglottoplasty
9,11—13],  technical  modiﬁcations  have  mainly  concerned
he  site  and  extent  of  the  tissues  to  be  resected.  The
urgical  technique  [14]  usually  consists  of  division  of  short
ryepiglottic  folds,  and  sometimes  a resection  of  excess
upra-arytenoid  mucosal  tissue  (Fig.  1),  section  of  the
edian  glossoepiglottic  ligament  with  suspension  of  the
piglottis  to  the  base  of  the  tongue,  partial  epiglottectomy
15]  or  a  combination  of  several  of  these  techniques.  Supra-
lottoplasty  is  usually  bilateral,  but  some  authors  have
ighlighted  the  advantages  and  disadvantages  of  unilateral
ersus  bilateral  supraglottoplasty  and  have  reported  a
ower  risk  of  supraglottic  stenosis  after  unilateral  supra-
lottoplasty  [16]. Various  methods  have  also  been  proposed
or  resection  of  excess  tissues:  cold  microinstruments
microscissors),  CO2 laser,  Thulium  laser  [17], diode  laser,
icrodebriders  [14]  and  no  differences  in  terms  of  the
esults  obtained  with  these  various  techniques  have  been
eported  in  the  literature  [18]. According  to  some  authors,
he  advantages  of  laser  and  microdebrider  compared  to
icroscissors  are  the  absence  of  intraoperative  bleeding,  a
ecreased  risk  of  oedema  and  simpliﬁcation  of  the  operative
echnique.  Lasers  and  microdebriders  are  more  expensive
han  classical  microsurgery  instruments  and  lasers  require
pecial  precautions  to  avoid  the  risk  of  ﬁre  during  surgery.
Management  of  laryngomalacia  
Figure  1  CO2 laser  division  of  the  aryepiglottic  folds  in  a  non-
intubated  infant.  A.  Supraglottic  stenosis  with  a  tube-shaped
epiglottis  and  short  aryepiglottic  folds  (1).  B.  Start  of  CO2 laser
division  of  the  aryepiglottic  folds  (2)  at  the  free  edge  of  the
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other  aetiologies,  such  as  gastro-oesophageal  reﬂux;  whichepiglottis  and  the  ventricular  fold.  C.  Appearance  of  the  left
aryepiglottic  fold  after  resection  (4)  —  glottis  (3).
Hospitalisation  is  usually  scheduled  when  upper  airway
endoscopy  is  indicated  in  the  setting  of  severe  laryngomala-
cia.  Depending  on  the  severity  of  the  symptoms  (especially
respiratory  distress)  and  the  comorbidity  associated  with
laryngomalacia,  a  bed  is  reserved  in  the  paediatric  inten-
sive  care  unit  postoperatively.  Endoscopy  under  general
anaesthesia  may  start  with  nasal  endoscopy  on  induction  of
anaesthesia  to  allow  dynamic  examination  of  the  infant’s
larynx  under  optimal  conditions  (sedated  infant)  and  to
detect  any  sleep-related  or  sleep-exacerbated  diseases.
Deeper  general  anaesthesia  is  then  ensured  by  intravenous
anaesthetics  and  anaesthetic  gases  and  rigid  endoscopy
is  ideally  performed  under  spontaneous  breathing.  A  dose
of  systemic  corticosteroids  (methylprednisolone  2  mg/kg)
is  administered  at  the  beginning  of  the  procedure.  Local
anaesthesia  of  the  glottic  and  supraglottic  regions  is
performed.  Direct  laryngoscopy  (Pearson  or  Benjamin
spatula)  and  rigid  bronchoscopy  are  performed  to  conﬁrm
laryngomalacia  and  to  deﬁne  the  most  appropriate  surgical
m
s
a17
rocedure  based  on  the  anatomical  type  of  laryngomalacia,
nd  to  detect  any  concomitant  respiratory  tract  lesions.
urgical  treatment  of  laryngomalacia  is  then  performed
uring  direct  laryngoscopy  (suspension  laryngoscopy)  using
n  endoscope  or  an  operating  microscope.  The  surgical
rocedure  most  commonly  performed  is  division  of  the
ryepiglottic  folds,  possibly  combined  with  resection
f  excess  supra-arytenoid  mucosa  (Fig.  1).  Resection  of
ucosal  tissue  must  be  performed  very  cautiously  and  must
emain  away  from  the  midline  in  the  inter-arytenoid  zone  to
ecrease  the  risk  of  postoperative  supraglottic  stenosis  of
he  larynx.  Laser  can  be  used  in  continuous  mode  at  a  power
f  about  1  Watt  for  CO2 laser  or  1.5  Watt  for  Thulium  laser.
hen  using  a microdebrider,  the  recommended  power  is  800
.p.m.  in  oscillating  mode,  without  irrigation,  using  a  2.9  or
.5  mm  diameter  laryngeal  blade.  Haemostasis  and  cleaning
f  the  operative  ﬁeld  are  performed  with  compresses  soaked
n  adrenaline  saline  (1  mg  of  adrenaline  in  10  ml  of  saline).
piglottopexy  is  not  performed  as  ﬁrst-line  procedure,
xcept  for  a  few  teams  [19,20],  but  only  following  failure
f  previous  techniques  with  persistent  posterior  prolapse
f  the  epiglottis.  In  this  situation,  laser  vaporisation  is
erformed  on  the  lingual  surface  of  the  epiglottis  over  the
edian  glossoepiglottic  ligament  to  create  a  raw  surface
nd  epiglottopexy  is  then  performed  between  the  epiglottis
nd  the  base  of  the  tongue  with  resorbable  suture  material
Vicryl  3/0).  Finally,  partial  resection  of  the  suprahyoid
ortion  of  the  epiglottis  (traction  with  forceps  applied  to
he  median  aspect  of  the  epiglottis  and  partial  C-shaped
piglottectomy  using  microscissors  or  laser)  is  rarely  per-
ormed  and  tracheotomy  can  be  proposed  following  failure
f  these  various  procedures.
ndications  for  surgical  management
aryngomalacia  is  the  most  common  laryngeal  abnormality
nd  usually  has  a  favourable  outcome  [6,21]. Only  10  to
0%  of  infants  present  severe  laryngomalacia  requiring  sur-
ical  management  [22,23]. The  criteria  used  to  deﬁne  the
everity  of  laryngomalacia  vary  from  one  author  to  another
5],  but  all  authors  take  into  account  the  severity  of  the
ymptoms  associated  with  stridor.  Surgery  should  therefore
e  proposed  when  laryngomalacia  is  associated  with  one  or
ore  of  the  following  symptoms:
dyspnoea  with  permanent  and  severe  intercostal  or
xyphoid  retraction;
 episodes  of  respiratory  distress;
 obstructive  sleep  apnoea;
 episodes  of  suffocation  while  feeding  or  feeding  difﬁcul-
ties;
 poor  weight  gain.
Note  that  some  of  these  symptoms  can  be  associated  withust  be  identiﬁed  and  treated  before  deciding  to  perform
urgery.  Finally,  the  family  setting  must  also  be  taken  into
ccount  in  the  treatment  decision.
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valuation  of  surgical  treatment  —  Efﬁcacy
urgical  treatment  of  laryngomalacia  provides  rapid  and
asting  improvement  in  70%  to  100%  of  cases  (Table  1).
owever,  the  results  of  the  various  published  series
ust  be  compared  very  cautiously,  as  patient  selec-
ion  or  postoperative  evaluation  of  operated  patients  are
ften  based  on  subjective  criteria  with  marked  variability
etween  teams.  A  marked  reduction  or  even  complete  reso-
ution  of  stridor  is  usually  observed  after  surgery,  as  well  as
esolution  of  the  cyanotic  and  apnoeic  episodes  described
y  the  parents  and  improvement  of  oxygen  saturation  on
onitoring.  After  the  ﬁrst  early  postoperative  phase  (seven
o  15  days),  during  which  feeding  can  be  difﬁcult  (especially
fter  the  use  of  laser  techniques),  a  marked  improvement
f  feeding  is  observed  (absence  of  suffocation  and  rapid
ngestion  of  bottles  [less  than  15  minutes]).  However,  dete-
ioration  may  be  observed  in  the  presence  of  pre-existing
wallowing  disorders.  Weight  gain  returns  to  normal  after
he  ﬁrst  postoperative  month.  Improvement  of  respiratory
ifﬁculties  is  also  observed,  with  resolution  of  intercostal
ecession.  Some  authors  perform  early  follow-up  endoscopy,
efore  discharge  from  hospital,  to  eliminate  any  early
ynechiae.  All  authors  perform  nasal  endoscopy  at  an  ofﬁce
isit,  three  to  four  weeks  after  surgery.  Nasal  endoscopy
eveals  good  healing  of  the  larynx  and  marked  improvement
f  collapse  of  the  supraglottic  part  of  the  larynx.
Evaluation  of  efﬁcacy  should  be  based  on  objective
linical  criteria  (height  and  weight  gain)  or  functional
riteria  (polysomnography,  echocardiography  in  the  pres-
nce  of  pulmonary  artery  hypertension).  Polysomnography
llows  recording  of  apnoeas,  hypopnoeas,  and  oxygen
aturation  and  can  be  combined  with  measurement  of
as  exchanges  during  sleep  especially  transcutaneous  CO2
PtcCO2).  Several  teams  propose  polysomnography  before
t
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Table  1  Various  series  published  in  the  literature  according  to  [1
O’Donnel
et  al.  [18]
Martin
et  al.  [43]
Toynton
et  al.  [23]
Roge
et  al
Year  2007  2005  2001  1995
Number of  infants  84  30  100  115  
Improvement  of
stridor  (%  of
cases)
88.1  90  86  89  
Micro-inhalations
or aspirations  (%
of  cases)
7.1  13  6  
Need for
tracheotomy  (%
of  cases)
0  6.7  1  1.7  
Need for  redo
procedure  (%  of
cases)
4.8 3.3  1.7  
Mean hospital  stay  1.5  day
(13.2  in
the
presence
of  comor-
bidity)
5.3  day
(12.9  in
the
presence
of  comor-
bidity)S.  Ayari  et  al.
ny  surgical  procedure  [24,25], except  in  an  emergency.
his  initial  examination  can  then  be  used  as  the  reference
aseline  examination  to  be  compared  with  postoperative
ecordings  in  the  event  of  failure  of  treatment  or  only
artial  clinical  improvement.
Several  series  have  reported  the  objective  results  of  the
fﬁcacy  of  surgical  treatment  of  laryngomalacia  based  on
reoperative  and  postoperative  polysomnography  [24—27]
ith  improvement  of  the  apnoea/hypopnoea  index  (AHI).
owever,  these  series  were  based  on  limited  sample  sizes
nd  postoperative  polysomnography  was  performed  at
ariable  intervals  after  surgery.  Polysomnography  clearly
onstitutes  a  very  useful  tool  for  evaluation  of  the  severity
f  laryngomalacia  and  the  efﬁcacy  of  treatment.  However,
outine  use  of  polysomnography  would  be  difﬁcult  in  most
entres  due  to  the  prohibitive  cost  and  especially  the
imited  access  to  this  examination  with  long  waiting  times.
Other  authors  have  reported  improvement  of  gastro-
esophageal  reﬂux  [28]  after  aryepiglottoplasty.
isks  of  failure  of  surgery
he  risk  of  treatment  failure  is  higher  in  infants  with  a
oncomitant  disease.  Denoyelle  et  al.,  based  on  a  series  of
36  infants,  observed  failure  of  surgical  treatment  (n  =  5)
or  only  partial  improvement  of  the  symptoms,  n  =  7)  only
n  patients  presenting  laryngomalacia  associated  with  other
ongenital  anomalies  [4].  Schroeder  et  al.  also  had  to
ore  frequently  use  postoperative  adjuvant  respiratory
herapy  (nebulization,  noninvasive  ventilation,  oxygen
herapy,  intubation)  in  children  with  encephalopathy  or
aryngomalacia  associated  with  subglottic  stenosis  [29].
alera  et  al.  observed  treatment  failure  in  three  patients
ith  associated  tracheomalacia  or  encephalopathy  [27]  in  a
8].
r
.  [22]
Polonovski
et  al.  [31]
Remacle
et  al.  [44]
McClurg
et  al.  [42]
Whymark
et  al.  [20]
 1990  1996  1994  2006
39  12  24  59
97  100  71  73
0  0  7
2.6  14
5.1  50  12
48  h  for
most
infants
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mManagement  of  laryngomalacia  
series  of  59  infants  treated  surgically  for  severe  laryngoma-
lacia,  while  no  failure  was  observed  in  infants  with  isolated
laryngomalacia.  In  contrast,  out  of  ten  infants  with  a
neurological  condition,  one  required  redo  laryngoplasty  and
six  required  tracheotomy  after  failure  of  supraglottoplasty.
In  the  same  series,  ten  infants  presented  cardiac  anomalies
and  three  of  them  required  tracheotomy  after  failure  of
surgery.  Two  of  the  eight  infants  with  congenital  malforma-
tion  syndrome  (one  infant  with  Pierre  Robin  sequence  and
another  with  Down  syndrome)  required  tracheotomy.  In  the
absence  of  comorbidity,  age  at  the  time  of  surgery  less  than
2  months  appears  to  be  associated  with  a  higher  incidence  of
redo  supraglottoplasty  compared  to  children  operated  after
the  age  of  2  months  (6.4%  vs  5.3%  in  the  study  by  Hoff  [30]).
Evaluation  of  the  surgical
treatment  —  Complications
Complications  of  surgical  treatment  of  laryngomalacia  are
fairly  rare  in  view  of  the  young  age  of  the  infants  concerned
and  the  frequency  of  comorbid  conditions,  particularly
congenital  malformations.  Most  series  [3,4,31]  report
complication  rates  less  than  10%.  However,  the  presence
of  neurological  or  cardiac  comorbidity  and  age  less  than
2  months  constitute  major  risk  factors  for  failure  and/or
complications  [30]. Laryngeal  spasm  or  laryngeal  oedema
during  the  perioperative  period  may  require  intubation.
Local  postoperative  complications  include:
•  granulomas,  haemorrhage,  adhesions  that  can  cause
supraglottic  stenosis,  infection,  transient  aspiration.  An
overly  aggressive  surgical  technique  (especially  laser  or
excessive  resection  with  cold  instruments)  or  gastro-
oesophageal  reﬂux  could  explain  these  complications,
but  no  particular  technique  and  poorly  controlled  gastro-
oesophageal  reﬂux  do  not  appear  to  be  associated  with  a
higher  risk  of  complications  [32];
• failure  to  recognize  an  associated  laryngotracheal
lesion  (subglottic  stenosis,  tracheomalacia)  that  may
compromise  postoperative  extubation,  requiring  tra-
cheotomy  [30].
Long-term  complications  are  essentially  lower  respira-
tory  tract  infections  related  to  aspiration  or  complications
related  to  decompensation  of  associated  malformations
(cardiac,  renal,  cerebral  etc.).
Methods and indications for  noninvasive
ventilation in laryngomalacia
Indications
Noninvasive  ventilation  (NIV)  decreases  the  respiratory  work
of  infants  with  upper  airway  obstruction  associated  with
alveolar  hypoventilation  [33,34],  especially  laryngomalacia
[35,36].  It  allows  improvement  of  nocturnal  gas  exchanges
[36]  and  maintenance  of  satisfactory  weight  and  height  gain
[36].  Fauroux  et  al.  demonstrated  the  efﬁcacy  of  Bilevel
Positive  Airway  Pressure  (BIPAP)  comprising  pressure  sup-
port  and  positive  end-expiratory  pressure  [36]  in  12  children
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ith  a  mean  age  of  33  months  (8—79  months,  three  infants
ess  than  1  year  old).  Essouri  et  al.  also  demonstrated  the
fﬁcacy  of  continuous  positive  airway  pressure  (CPAP)  venti-
ation  [35]  in  ten  infants  with  a  mean  age  of  10  months  (3—18
onths)  presenting  upper  airway  obstruction  (ﬁve  cases  of
aryngomalacia,  three  cases  of  tracheomalacia).
NIV  can  avoid  tracheotomy  and  its  consequences:  can-
ula  obstruction,  discomfort,  delayed  speech  development,
amily  consequences  [37,38]. In  2006,  a  consensus  (SFAR,
PLF,  SRLF)  considered  that  NIV  should  be  proposed  for
he  management  of  acute  respiratory  failure  secondary  to
aryngo-tracheomalacia  [39]. However,  no  guidelines  are
vailable  for  isolated  laryngomalacia,  either  in  a  context
f  acute  decompensation  or  for  chronic  management.
The  expert  group  proposed  the  use  of  NIV  in  laryngoma-
acia,  either  isolated  or  part  of  a  congenital  malformation
yndrome,  with  signs  of  severity  [35,36]  complicated  by
leep-disordered  breathing  (apnoeas,  gas  exchange  anoma-
ies),  poor  weight  gain  or,  in  extreme  cases,  pulmonary
rtery  hypertension  when  surgical  treatment  cannot  be  pro-
osed  (or  while  waiting  for  surgery)  or  when  medical  and
urgical  treatment  is  not  sufﬁciently  effective.
ethods
o  guidelines  are  available  concerning  the  modalities  of
IV  for  infants  with  laryngomalacia.  However,  the  guide-
ines  published  by  the  Association  Franc¸aise  contre  les
yopathies  and  the  Haute  Autorité  de  la  santé  (French
ational  Authority  for  Health)  for  NIV  in  children  with
euromuscular  diseases  (Modalités  pratiques  de  la  VNI  en
ression  positive,  au  long  cours,  à  domicile,  dans  les  mal-
dies  neuromusculaires) can  be  used  as  a  guide.  NIV  must
e  performed  by  an  experienced  team  as  part  of  multi-
isciplinary  management  (ENT  and  maxillofacial  surgeons,
aediatric  respiratory  physicians,  nurses,  social  workers).
t  can  only  be  performed  with  the  family’s  agreement  and
ctive  cooperation  (HAS  recommendation  concerning  NIV  in
hildren  with  neuromuscular  diseases).
CPAP  or  BIPAP  can  be  used,  always  with  a  leakage  system.
he  sensitivity  of  the  inspiratory  trigger  of  the  ventilators
BIPAP  mode)  available  in  France  is  usually  poorly  adapted  to
nfants  [35,40]. It  is  therefore  preferable  to  start  with  CPAP
entilation,  which  maintains  constant  upper  airway  opening
hroughout  the  respiratory  cycle  [33—35], as  Essouri  et  al.
howed  that  BIPAP  causes  more  marked  asynchronism  than
PAP.  However,  BIPAP  with  a  minimum  frequency  adjusted
o  the  respiratory  rate  in  infants  (thereby  avoiding  the  use
f  the  inspiratory  trigger)  can  be  used  to  limit  this  asynchro-
ism.  The  pressures  used  depend  on  the  course  of  clinical
clinical  examination,  weight  gain,  the  infant’s  develop-
ent)  and  functional  parameters  (apnoeas,  gas  exchanges).
The  interface  used  must  be  adapted  to  the  infant’s  face.
 nasal  mask  is  generally  used  and  the  choice  of  this  mask
s  essential,  either  a  commercially  available  mask  (but  few
asks  are  available  for  low  weight  infants)  or  handmade
ask  moulded  onto  the  infant’s  face.  The  mask  must  be  com-ortable,  must  not  irritate  the  skin,  and  must  not  cause  any
eaks.  Use  of  a  teat,  to  limit  mouth  leaks,  is  often  effective
nd  usually  better  tolerated  that  a  chinstrap.  Assessment
f  the  short-term  tolerability  of  the  mask  is  an  essential
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art  of  surveillance.  NIV  is  generally  used  during  sleep,
hich  can  represent  the  majority  of  the  24-hour  period  in
nfants.  There  is  a  risk  of  skin  lesions  or  facial  deformities
econdary  to  the  pressures  exerted  by  the  mask  on  grow-
ng  facial  structures  [41]. In  a  cohort  study  of  40  ventilated
atients  (16  infants  with  OSAS,  14  infants  with  neuromuscu-
ar  disease,  ten  infants  with  cystic  ﬁbrosis)  with  a  mean  age
f  10  years  (0.6—18),  Fauroux  et  al.  reported  skin  lesions
n  48%  of  cases,  maxillary  retrusion  in  37%  of  cases,  and
lobal  ﬂattening  of  the  face  in  68%  of  cases.  No  correlation
as  observed  between  these  complications  and  the  infant’s
ge,  the  type  of  mask,  or  the  underlying  disease.  In  con-
rast,  the  risk  increased  with  the  duration  of  use  of  daytime
IV  (OR  =  6.3).  Follow-up  by  a  maxillofacial  surgical  team  is
herefore  essential.
onclusion
aryngomalacia  is  the  most  common  laryngeal  disease  in
nfants.  It  is  poorly  tolerated  in  10%  of  cases,  requiring
ssessment  and  surgical  management  as  well  as  manage-
ent  of  any  associated  gastro-oesophageal  reﬂux.  Surgery
ffectively  controls  symptoms,  but  few  data  are  available
oncerning  objective  assessment  of  the  results:  preopera-
ive  and  postoperative  objective  assessment  of  these  infants
ust  be  performed  whenever  possible.  However,  NIV  may  be
ndicated  in  some  infants  with  comorbid  diseases  or  who  fail
o  respond  to  surgical  treatment.
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